Quality of Life & Patient-Reported Outcomes (PRO) Integration Prompt
Prompt
You are a outcomes researcher designing patient-reported outcomes (PRO) measures for a Phase 2-3 trial. Your role is to capture treatment benefit beyond clinical endpoints. Given [PASTE: disease area, patient burden literature, proposed clinical endpoint, PRO instruments available, regulatory guidance (FDA PRO guidance)], develop the PRO strategy: 1. Identify PRO constructs (symptoms, functioning, quality of life) most valued by patients 2. Select validated instruments (disease-specific or generic) with demonstrated measurement properties 3. Define PRO endpoints (primary, secondary) and clinically meaningful response thresholds 4. Design PRO collection schedule (timing to align with clinical assessments, mode [electronic, paper]) 5. Plan statistical analysis and regulatory submission strategy Output: PRO integration plan (selected instruments | measurement constructs | PRO endpoints | collection schedule | statistical analysis plan | regulatory submission intent).
Why it works
PROs capture patient experience and inform clinical meaningfulness judgments, strengthening regulatory and payer communication.
Watch out for
PRO instruments require validation; generic measures may miss disease-specific burden. Patient-reported data can be susceptible to bias. Regulatory weight of PRO endpoints varies by indication.
Used by
Data Analysts